Michael Ricciardi, Ph.D.
Login to view DISC.Michael Ricciardi is the Executive Director of Translational Research at The George Washington University, where he leads projects developing monoclonal antibodies for infectious diseases like COVID-19, HIV, and Zika. He holds a Ph. D. in Biochemistry and Molecular Biology from the University of Miami Miller School of Medicine and has extensive experience in commercializing biomedical products.
He is a driven entrepreneur, having co-founded two biotechnology companies, MABloc Therapeutics and MAT Biologics. These companies focus on antibody discovery and development, and the acquisition of human samples for research, respectively, showcasing his passion for translating scientific discoveries into practical solutions for global health challenges.
Unique fact: Michael is a co-inventor on a patent for a broadly-neutralizing antibody designed to combat COVID-19 and other coronaviruses.
Read the full overview →How Michael shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Michael cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other The George Washington University Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.